NCT04196452View on ClinicalTrials.gov

A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)

Active, not recruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

December 20, 2033

Study Completion Date

June 30, 2034

Conditions
Melanoma
Interventions
DRUG

Ipilimumab

Specified dose on specified days

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY